Ghost Tree Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Ghost Tree Capital’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$704K	–	75
2023 Q2	$704K	Sell	100,000 -900,000	-90%	-$6.44M	0.23%	50
2023 Q1	$6.11M	Sell	1,000,000 -300,000	-23%	-$2.07M	1.81%	22
2022 Q4	$8.31M	Buy	+1,300,000	New	+$10.1M	3.55%	12
2021 Q4	–	Sell	-700,000	Closed	-$15.4M	–	62
2021 Q3	$17.3M	Buy	700,000 +250,000	+56%	+$5.89M	5.05%	3
2021 Q2	$11.7M	Sell	450,000 -50,000	-10%	-$1.3M	3.22%	11
2021 Q1	$15.8M	Hold	500,000	–	–	3.72%	7
2020 Q4	$23.2M	Sell	500,000 -75,000	-13%	-$2.98M	5.17%	5
2020 Q3	$18.9M	Sell	575,000 -5,000	-0.9%	-$153K	5.47%	5
2020 Q2	$15.9M	Buy	580,000 +230,000	+66%	+$7.56M	4.2%	7
2020 Q1	$10.5M	Sell	350,000 -300,000	-46%	-$7.95M	2.78%	13
2019 Q4	$18M	Buy	650,000 +150,000	+30%	+$3.41M	3.43%	7
2019 Q3	$9.1M	Buy	500,000 +350,000	+233%	+$7.74M	2.32%	18
2019 Q2	$3.68M	Sell	150,000 -1,000,000	-87%	-$15.1M	0.76%	34
2019 Q1	$10.9M	Buy	1,150,000 +150,000	+15%	+$1.46M	2.86%	14
2018 Q4	$8.85M	Buy	+1,000,000	New	+$9.64M	3.21%	11
2018 Q3	–	Sell	-360,000	Closed	-$4.61M	–	58
2018 Q2	$4.61M	Sell	360,000 -640,000	-64%	-$9.35M	1.36%	27
2018 Q1	$16.9M	Buy	+1,000,000	New	+$15.1M	3.42%	6
2017 Q3	–	Sell	-550,000	Closed	-$4.04M	–	70
2017 Q2	$4.04M	Sell	550,000 -650,000	-54%	-$4.13M	0.84%	45
2017 Q1	$8.94M	Buy	1,200,000 +225,000	+23%	+$1.65M	1.67%	24
2016 Q4	$6.78M	Buy	975,000 +150,000	+18%	+$1.03M	1.63%	23
2016 Q3	$6.79M	Buy	825,000 +125,000	+18%	+$1.06M	1.1%	32
2016 Q2	$5.67M	Buy	700,000 +450,000	+180%	+$2.83M	1.64%	24
2016 Q1	$1.27M	Buy	+250,000	New	+$1.37M	0.72%	40
2015 Q4	–	Sell	-300,000	Closed	-$1.73M	–	62
2015 Q3	$1.73M	Sell	300,000 -50,000	-14%	-$389K	0.78%	48
2015 Q2	$3.21M	Buy	350,000 +150,000	+75%	+$1.67M	1.04%	44
2015 Q1	$2.42M	Buy	+200,000	New	+$2.25M	0.87%	48

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ghost Tree Capital's IOVA Position: Q3 2023 in Review

Ghost Tree Capital sold out of Iovance Biotherapeutics (IOVA) in Q3 2023, closing a stake of 100,000 shares — an estimated $704K sold.

Ghost Tree Capital first reported a position in IOVA in Q1 2015 and held it in 26 quarters. The position peaked at $23.2M in Q4 2020. 227 funds tracked by Wall St. Rank hold IOVA as of Q3 2023.

Ghost Tree Capital reported no remaining Iovance Biotherapeutics position as of Q3 2023 after selling out during the quarter.
Ghost Tree Capital sold 100,000 Iovance Biotherapeutics shares in Q3 2023, an estimated $704K.
Ghost Tree Capital first reported a position in Iovance Biotherapeutics in Q1 2015 and held it in 26 quarters.
Ghost Tree Capital's Iovance Biotherapeutics position peaked at $23.2M in Q4 2020.
227 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2023.

Based on Ghost Tree Capital's 13F filing for Q3 2023, filed 14 Nov 2023.